500 mg CK-2017357

DRUG3 trials

Sponsors

Cytokinetics

Conditions

Amyotrophic Lateral SclerosisIntermittent ClaudicationMyasthenia GravisPeripheral Artery Disease

Phase 2

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01089010

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2010-03-31End: 2010-11-30Updated: 2019-05-10

A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

CompletedNCT01131013

CytokineticsIntermittent Claudication, Peripheral Artery Disease

Start: 2010-05-31End: 2011-03-31Updated: 2019-05-14

Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

TerminatedNCT01268280

CytokineticsMyasthenia Gravis

Start: 2010-12-31End: 2012-10-31Updated: 2019-09-24

Related Papers

Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease

Vascular Medicine2014-05-289 citations